Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2017
Headcount
1
HQ
Kefar Sava, Israel
Sector
Health Tech & Life Sciences
About
KanaFem is aiming to develop and provide cannabis-based solutions for women, both for medicinal and recreational use. The company is developing products specifically for women in menopause and women with dysmenorrhea. KanaFem is also working on developing cannabis-based anti-aging cosmetic treatments. Bazelet Pharma is in charge of KanaFem's R&D.
Q&A
- What is KanaFem's primary focus?
- KanaFem aims to develop and provide cannabis-based solutions for women, targeting medicinal and recreational use, specifically for menopause, dysmenorrhea, and anti-aging cosmetic treatments.
- When was KanaFem founded?
- KanaFem was founded in August 2017.
- What is the current status of KanaFem?
- KanaFem is currently inactive and ceased to operate in June 2020.
- Where is KanaFem headquartered?
- KanaFem is headquartered in Kefar Sava, Center District, Israel.
- Which company is responsible for KanaFem's R&D?
- Bazelet Pharma is in charge of KanaFem's R&D.
- What sector does KanaFem operate in?
- KanaFem operates in the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Medical Cannabis.
Team · 4
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
ConsumersDemographics & FamilyWomenRecreational & LifestyleCannabisHealthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2C
Highlights
Verified
Tags
personalized-medicinepharmaceuticalswomenwomen-healthanti-agingpatient-engagementmedical-cannabispersonalizationcannabiswellness
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/27205773 | |
| facebook.com/kanafem |
Identifiers & details
| Founded | 2017-8 |
|---|---|
| Employees (exact) | 1 |
| Status reason | Non Active, Jun 2020 ceased to operate |